Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: LH

Labcorp Holdings Inc.

Healthcare | Medical - Diagnostics & Research
$254.91 -8.89 (-3.37%) as of 2026-07-14 20:28 UTC
Market Cap$20.9B
EPS (TTM)$10.46

Labcorp Holdings Inc. (NYSE: LH) is a $20.9B medical - diagnostics & research company trading at $254.91 (−3.4% today) — 24.4× trailing earnings, yielding 1.13%. Figures from SEC EDGAR and market feeds; updated 2026-07-14 20:28 UTC.

52-Week Range
Low $252.38High $279.54

What Labcorp Holdings Inc. does

Labcorp provides laboratory testing and drug development services to doctors, hospitals, pharmaceutical companies, researchers, and patients across approximately 100 countries. The company operates through two main business segments: diagnostics (Dx) and drug development laboratory services (BLS), supported by nearly 71,000 employees. The company performs clinical laboratory tests and supports drug development, including providing support for newly approved FDA drugs and therapeutic products.

Summarized from Labcorp Holdings Inc.’s SEC filings · Read the filing ↗

Key facts
Quote
Price$254.91
Change (1D)-8.89 (-3.37%)
Market cap$20.9B
52-week range$252.38 – $279.54
Valuation
P/E (TTM)24.37×
EV/EBITDA12.30×
EPS (TTM)$10.46
Dividend yield1.13%
Price/book2.43×
Return on equity10.17%
Debt/equity0.59
Returns
52-week return+1.0%
Revenue, margins & earnings
FY2021 Net income: $2.38BFY2021 Taxes & interest: $671MFY2021 Operating expenses: $1.94BFY2021 Cost of revenue: $8.14B$13.1BFY2021FY2022 Net income: $1.28BFY2022 Taxes & interest: $157MFY2022 Operating expenses: $2.27BFY2022 Cost of revenue: $8.15B$11.9BFY2022FY2023 Net income: $418MFY2023 Taxes & interest: $308MFY2023 Operating expenses: $2.64BFY2023 Cost of revenue: $8.80B$12.2BFY2023FY2024 Net income: $746MFY2024 Taxes & interest: $341MFY2024 Operating expenses: $2.54BFY2024 Cost of revenue: $9.38B$13.0BFY2024FY2025 Net income: $876MFY2025 Taxes & interest: $508MFY2025 Operating expenses: $2.63BFY2025 Cost of revenue: $9.94B$14.0BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-07-06
  • 2026-07-06Vaughn Bryan TEVP and President, DiagnosticsM327—
  • 2026-07-06Vaughn Bryan TEVP and President, DiagnosticsF-93$26.4K
  • 2026-07-06Vaughn Bryan TEVP and President, DiagnosticsSELL-234$67.0K
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • VANGUARD GROUP INC9,811,191$2.46B-0.0%
  • VANGUARD CAPITAL MANAGEMENT LLC5,376,120$1.43BNEW
  • BlackRock, Inc.5,170,898$1.38B-20.9%
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does Labcorp Holdings Inc. do?

Labcorp provides laboratory testing and drug development services to doctors, hospitals, pharmaceutical companies, researchers, and patients across approximately 100 countries.

What is LH's valuation?

LH trades at $254.91, 24.37× trailing earnings, 12.30× EV/EBITDA, as of 2026-07-14. It carries a 1.13% dividend yield.

When did LH last file with the SEC?

Labcorp Holdings Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-10. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 20:28 UTC. This page is also available as JSON at /api/data?ticker=LH and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for LH and 3,500+ tickers.

Create a free account — keep LH
For your agent
GET /api/data?ticker=LH

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt